Table 4.
Post-COVID-19 persisting symptoms/complaints and comorbidity.
| Name of the persisting symptom | Number of patients (n) | Percentage of the patients % |
|---|---|---|
| No complaint | 246 | 78.6 |
| Lethargy | 23 | 7.4 |
| Cough | 16 | 5.1 |
| Chest discomfort and pain | 12 | 3.8 |
| Fatigue | 12 | 3.8 |
| Breathlessness on activity | 12 | 3.8 |
| Anxiety, lack of concentration, and occasional amnesia | 5 | 1.6 |
| Headache | 4 | 1.2 |
| Fever (persisting fever) | 2 | 0.6 |
| Joint pain | 2 | 0.6 |
| Mild body ache | 1 | 0.3 |
| Chill | 1 | 0.3 |
| Enteric fever | 1 | 0.3 |
| Back pain | 1 | 0.3 |
| T2DM (following COVID-19) | 2 | 0.64 |
| HTN (following COVID-19) | 4 | 1.28 |
| Post-COVID uncontrolled DM | 9 | 54.55 |
| Post-COVID uncontrolled HTN | 8 | 34.78 |
COVID-19, coronavirus disease 2019; HTN, hypertension; T2DM, Type 2 diabetes mellitus.